Tower Pharmacy and Compounding
Form 483 issued September 19, 2019 · Mission Viejo, California
- Inspection
- Sep 9 – Sep 19, 2019
- Investigator
- Christopher R. Czajka
- Observations
- 2
- Pages
- 4
- FEI number
- 3010504654
In short: On September 19, 2019, FDA issued a Form 483 with 2 observations to Tower Pharmacy and Compounding in Mission Viejo, California (FEI 3010504654) after an inspection that ran Sep 9 – Sep 19, 2019. The investigator was Christopher R. Czajka.
What FDA observed
Preview: the opening words of each observation- 01FDCA 501(a)(2)(A)
You produced highly potent drugs without providing adequate containment, segregation, cleaning of utensils and cleaning of…
- 02FDCA 501(a)(2)(A)
You used a non-pharmaceutical grade component in the formulation…
This inspection in context
Christopher R. Czajka
37 documents · 2015–2025
Cites FDCA 501(a)(2)(A) (insanitary conditions) more than any other section. Most of their documents are for sites in California.
The firmTower Pharmacy and Compounding history
The site's inspection history, in date order.
Similar 483sMore form 483s
Browse other documents of this type.
Questions about this 483
What did FDA find at Tower Pharmacy and Compounding?
FDA listed 2 observations on this Form 483. The opening words of each observation are shown on this page.
Who inspected Tower Pharmacy and Compounding?
Christopher R. Czajka is named on this Form 483, for the inspection of Sep 9 – Sep 19, 2019. Each investigator has a profile showing what they cite most.
When was Tower Pharmacy and Compounding inspected by FDA?
The inspection ran Sep 9 – Sep 19, 2019, and the Form 483 is dated September 19, 2019.
How do I get the full Form 483 for Tower Pharmacy and Compounding?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.